SENATE DOCKET, NO. 1526        FILED ON: 1/19/2023

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1428

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Michael O. Moore

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to smoking cessation agents.

_______________

PETITION OF:

 

Name:

District/Address:

 

Michael O. Moore

Second Worcester

 

Brian W. Murray

10th Worcester

6/27/2023


SENATE DOCKET, NO. 1526        FILED ON: 1/19/2023

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1428

By Mr. Moore, a petition (accompanied by bill, Senate, No. 1428) of Michael O. Moore for legislation relative to smoking cessation agents.  Public Health.

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 1490 OF 2021-2022.]

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Third General Court
(2023-2024)

_______________

 

An Act relative to smoking cessation agents.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

Chapter 94C of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by inserting after section 19D the following section:-

Section 19E. (a) Notwithstanding any other law, a licensed pharmacist may dispense Smoking Cessation Agents in accordance with written, standardized procedures or protocols developed by an actively practicing physician registered with the commissioner to distribute or dispense a controlled substance in the course of professional practice pursuant to section 7 if such procedures or protocols are filed at the pharmacist’s place of practice and with the board of registration in pharmacy before implementation.

(b) Before dispensing Smoking Cessation Agents authorized under this section, a pharmacist shall complete a training program approved by the commissioner, which shall include but not be limited to proper documentation, quality assurance and referral to additional services, including appropriate recommendation that the patient follow-up with a medical practitioner.

(c) The department of public health, board of registration in medicine and board of registration in pharmacy shall adopt regulations to implement this section.